Report an accessibility problem

Institutional Biosafety Committee

NOTICE 3.11.24: ASU IBC has developed a FAQ document to assist researchers with commonly asked IBC ERA-related questions. Researchers are encouraged to review this document and may contact if additional clarification is needed.


The Institutional Biosafety Committee (IBC) is responsible for the review and oversight of research or teaching conducted under the auspices of Arizona State University that utilizes recombinant or synthetic nucleic acid molecules, biohazards or infectious agents, select agents and toxins, or dual use research of concern (DURC).  

The IBC has established and implemented policies and procedures to provide for the safe and ethical conduct of research and teaching activities involving all biohazards and to facilitate compliance with the National Institutes of Health’s “Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules,” and other university, sponsor, federal, state, and local laws and regulations. 

The IBC is supported and administered through the Office of Research Integrity and Assurance (ORIA). Environmental Health & Safety’s (EH&S) Biosafety and Biosecurity unit supports the IBC through training, expertise, and laboratory inspections. In working together, we are committed to support ASU’s culture of safety.